These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 27035278

  • 1. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2.
    Zhang L, Wang W, Li X, He S, Yao J, Wang X, Zhang D, Sun X.
    Int J Oncol; 2016 Jun; 48(6):2425-34. PubMed ID: 27035278
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
    Tu K, Liu Z, Yao B, Han S, Yang W.
    Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.
    Yang W, Dou C, Wang Y, Jia Y, Li C, Zheng X, Tu K.
    Oncol Rep; 2015 Nov; 34(5):2576-84. PubMed ID: 26323375
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
    Liu Z, Wang Y, Dou C, Sun L, Li Q, Wang L, Xu Q, Yang W, Liu Q, Tu K.
    J Exp Clin Cancer Res; 2018 Mar 06; 37(1):49. PubMed ID: 29510736
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.
    Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082
    [Abstract] [Full Text] [Related]

  • 7. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF, Zhang MF, Tian QH, Fu J, Yang X, Zhang CZ, Yang H.
    Mol Cancer; 2018 Aug 08; 17(1):117. PubMed ID: 30089483
    [Abstract] [Full Text] [Related]

  • 8. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
    Kan H, Huang Y, Li X, Liu D, Chen J, Shu M.
    Oncotarget; 2016 Mar 22; 7(12):14336-49. PubMed ID: 26893361
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y, Guo X, Xiong L, Yu L, Li Z, Guo Q, Li Z, Li B, Lin N.
    Mol Cancer; 2014 Nov 26; 13():253. PubMed ID: 25424347
    [Abstract] [Full Text] [Related]

  • 10. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar 26; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

  • 11. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
    Du X, Fan W, Chen Y.
    Gene; 2018 May 30; 657():30-38. PubMed ID: 29505836
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.
    Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554
    [Abstract] [Full Text] [Related]

  • 14. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y, Jia Y, Li Q, Zhang H, Tu K, Song T, Liu Q.
    Oncotarget; 2016 Jun 14; 7(24):36909-36923. PubMed ID: 27191994
    [Abstract] [Full Text] [Related]

  • 15. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
    Fang F, Song T, Zhang T, Cui Y, Zhang G, Xiong Q.
    Oncotarget; 2017 May 09; 8(19):31745-31757. PubMed ID: 28423650
    [Abstract] [Full Text] [Related]

  • 16. Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.
    Zhang Y, Zhang D, Jiang J, Dong L.
    Oncol Rep; 2017 Jan 09; 37(1):323-332. PubMed ID: 27878280
    [Abstract] [Full Text] [Related]

  • 17. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
    Chen L, Guan H, Gu C, Cao Y, Shao J, Wang F.
    Tumour Biol; 2016 Feb 09; 37(2):2497-507. PubMed ID: 26385772
    [Abstract] [Full Text] [Related]

  • 18. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
    Zhang J, Cheng J, Zeng Z, Wang Y, Li X, Xie Q, Jia J, Yan Y, Guo Z, Gao J, Yao M, Chen X, Lu F.
    Oncotarget; 2015 Dec 08; 6(39):42040-52. PubMed ID: 26547929
    [Abstract] [Full Text] [Related]

  • 19. BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1.
    Tu K, Liu Z, Yao B, Xue Y, Xu M, Dou C, Yin G, Wang J.
    Oncol Rep; 2016 Apr 08; 35(4):2382-90. PubMed ID: 26882953
    [Abstract] [Full Text] [Related]

  • 20. Upregulated microRNA-429 inhibits the migration of HCC cells by targeting TRAF6 through the NF-κB pathway.
    Wang P, Cao J, Liu S, Pan H, Liu X, Sui A, Wang L, Yao R, Liu Z, Liang J.
    Oncol Rep; 2017 May 08; 37(5):2883-2890. PubMed ID: 28440423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.